- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Jul 18, 2023
Distillery Therapeutics
Microbial polyketide for relapsing C. difficile infection
BioCentury | Jun 1, 2023
Deals
June 1 Quick Takes: Lonza expands ADC offering with Synaffix takeout
Plus: Owkin investing $50M to build cancer spatial omics consortium and updates from Pfizer, AbbVie, Eikon, Lexicon, Hookipa, AstraZeneca, CMS and more
BioCentury | Jul 6, 2022
Deals
July 5 Quick Takes: Details of Pfizer-Biohaven negotiations emerge
Plus second adcomm for Amylyx’s ALS therapy, female biotech leaders criticize SCOTUS decision, and updates from Juvisé, Syros and more
BioCentury | Mar 13, 2020
Tools & Techniques
How to feed the machine: lessons from an AI antibiotics study
A machine learning study uncovering a broad-spectrum antibiotic is a case study in matching models to data
BioCentury | Oct 31, 2016
Tools & Techniques
Slaying senescent cells
Why Unity is eliminating senescent cells to treat age-related conditions
BioCentury | Sep 22, 2016
Distillery Therapeutics
Therapeutics: Aldehyde dehydrogenase 1 family member A1 (ALDH1A1); cytochrome P450 26A1 (CYP26A1; CP26)
Items per page:
1 - 10 of 114